|
|
Conference Speakers
Professor Sir Peter Gluckman
Chief Science Advisor to the Prime Minister
Prof Sir Peter D Gluckman KNZM FRSNZ FMedSci FRS is Chief Science Advisor to the Prime Minister. He is also University Distinguished Professor, Professor of Paediatric and Perinatal Biology and Director Emeritus in the Liggins Institute University of Auckland and Programmer Director, Singapore Institute for Clinical Sciences.
His own research spans from molecular to economic, encompassing the regulation of fetal and postnatal development, the long term consequences to poor start to life, and the evolutionary-medical interface. This has an agricultural as well as human perspective.
He has taken an active role in promoting public engagement with science.
Dr Jonathan Sackier
Professor of Surgery, University of Virginia;
President of Paradigm Shift Healthcare
Jonathan Sackier is Professor of Surgery at the University of Virginia. He helped introduce laparoscopic surgery and has been widely published.
Jonathan has brought many technologies to market including AESOP, the first commercial surgical robot. He also started several other enterprises including a stem cell company in 1984 and has consulted for many companies. He sat on the Associate Board of AdvaMed and several corporate governance and advisory boards.
A frequent commentator in the media, he also developed celebrity patient advocacy campaigns such as the Carnie Wilson web-cast which drove increased attention to bariatric surgery.
Dr David C. Chilvers
Chief Executive NHS Innovations London Ltd
In 2005, David founded NHS Innovations London to develop innovative medical products and services from NHS hospitals in London for use in healthcare globally. David and his team developed the Xpedite Innovations Management & Virtual Product Development processes, which provide a pipeline of 20 to 30 new products each year.
David also founded ATcare, the UK’s first Assistive Technology Design and Development Centre and developed the novel concept for the Xcelerate Health Outcomes Unit for preclinical health economics and health outcomes studies. Xpedite Ventures was recently formed to provide Seed Funding to Healthcare start-up companies.
David obtained his Ph.D. in Clinical Biochemistry from the University of Leeds carrying out research in the department of Medical Physics and the MRC Mineral Metabolism Unit at Leeds General Infirmary. He initially worked as a scientific advisor to the United Nations Environment Program (UNEP) and the World Health Organisation (WHO) before moving into marketing with Hewlett-Packard in Germany. Subsequently he has worked internationally in a variety of senior and Board level marketing, business development and general management positions in multinational and start-up companies in the medical, biotechnology and IT industries including Quadrant Healthcare, LION Bioscience and Iomega.
Julie Christie
CEO, Eyeworks New Zealand and Australia
Julie Christie is the founder and CEO of Eyeworks New Zealand and Australia. Formerly known as Touchdown Productions, she formed the television production company in 1991 and sold to Dutch media group, Eyeworks, in early 2006. Julie was the first Australasian entertainment producer to break into the lucrative US market and has achieved most of her international success with unscripted formats including The Chair, Miss Popularity and Treasure Island. The company's format, most of which were first aired in New Zealand, have been licensed to 30 countries including the US, the UK, France, Germany and even Iraq!
After a long career in unscripted television, Julie produced her first television drama, Burying Brian and executive-produced her first feature film, The Tattooist. Julie also owns Sky's Living and Food channels and a resort in Fiji.
The mother of two is the recipient of the 2004 Women In Film and Television Award for International Achievement, the 2006 SPADA Independent Producer of the Year, the 2008 Veuve Clicquot Businesswoman of the Year and was last year made an Officer of The New Zealand Order of Merit.
Paul Chan
GM Health Sciences, Asia Pacific
UL International Limited (Hong Kong)
Paul graduated with a degree in Aerospace Engineering and started his career as an EMC engineer responsible for testing, technical competency and quality assurances. Paul’s efforts ensured his organisation was the first DATech EMC accredited laboratory in Hong Kong. Paul was one of a handful of overseas signatories for EMC reports under the Chinese accreditation system.
Paul has worked with leading certification institutions including TUV SUD as the Sales & Marketing Manager responsible for developing business in the Southern China region. Paul works for UL and was involved in Business Development for RoHS,EMC and Global Market Access before focusing on developing Medical Business in Asia Pacific.
Diane Foreman
Emerald Group Limited
Conference Dinner Guest Speaker
It’s not surprising that Diane Foreman was named the Ernst & Young Entrepreneur of the Year for 2009. Her portfolio under Emerald Group demonstrates not only financial success across a range of sectors but also an ability to see potential where others don’t or are currently failing.
Emerald Foods was purchased from an international company that had failed to make it profitable. Today its production of ice cream is so successful its New Zealand Natural brand is in 21 countries around the world. In fact every nine days a new outlet opens somewhere across the globe. Its investment in research and development has ensured new and exciting products to be produced many of them world firsts and award winners.
Diane’s true passion lies in her 23 percent shareholding in Healthcare Holdings. As a result of Diane’s drive to lift health standards for New Zealanders in addition to providing private hospital and clinic facilities through a 100 percent ownership of the MercyAscot Group, as a country we now have access to private radiotherapy. This joint venture with Southern Cross has ensured New Zealand’s public waiting lists are reducing. In October Healthcare Holdings purchased New Zealand’s first PET scanner.
Her boutique accommodation Emerald Inn is a far cry from the property she purchased from the receivers in 1995 and so are the occupancy rates! Her long-term plan for this property is a state-of-the-art retirement village.
Motivated to ensure Diane always had access to top talent she established Emergent with a 50 percent shareholding partner. All of Emerald Groups executives have come through Emergent.
Diane has for many years been involved in philanthropic activities particularly Hearing House. She has four children and two step-children.
|